129 related articles for article (PubMed ID: 37168295)
1. Occurrence of comorbid diseases in patients after COVID-19.
Kamilova U; Ermekbaeva A; Nuritdinov N; Khamraev A; Zakirova G
J Med Life; 2023 Mar; 16(3):447-450. PubMed ID: 37168295
[TBL] [Abstract][Full Text] [Related]
2. Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry.
Proietti M; Laroche C; Drozd M; Vijgen J; Cozma DC; Drozdz J; Maggioni AP; Boriani G; Lip GY;
Am Heart J; 2016 Nov; 181():83-91. PubMed ID: 27823697
[TBL] [Abstract][Full Text] [Related]
3. The association between relevant co-morbidities and prevalent as well as incident heart failure in patients with atrial fibrillation.
Wändell P; Carlsson AC; Holzmann MJ; Ärnlöv J; Sundquist J; Sundquist K
J Cardiol; 2018 Jul; 72(1):26-32. PubMed ID: 29358024
[TBL] [Abstract][Full Text] [Related]
4. [Atrial fibrillation in Mexican population: Differences in presentation, comorbidities and risk factors between men and women].
Rodríguez-Reyes H; Laguna-Muñoz CI; Gallegos-de Luna CF; de-Los-Ríos-Ibarra MO; Salas-Pacheco JL; Leyva-Pons JL; Muñoz-Gutiérrez LM; Vargas-Hernandez A; Rodríguez-Muñoz KM; Barragán-Luna J; Alcocer-Gamba MA; Cortez-Lawrenz J; Farjat-Ruiz J
Arch Cardiol Mex; 2022 Jul; 92(3):349-357. PubMed ID: 34758015
[TBL] [Abstract][Full Text] [Related]
5. [ACTIV SARS-CoV-2 registry (Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients). Assessment of impact of combined original comorbid diseases in patients with COVID-19 on the prognosis].
Arutyunov GP; Tarlovskaya EI; Arutyunov AG; Belenkov YN; Konradi AO; Lopatin YM; Rebrov AP; Tereshchenko SN; Chesnikova AI; Hayrapetyan HG; Babin AP; Bakulin IG; Bakulina NV; Balykova LA; Blagonravova AS; Boldina MV; Vaisberg AR; Galyavich AS; Gomonova VV; Grigorieva NY; Gubareva IV; Demko IV; Evzerikhina AV; Zharkov AV; Kamilova UK; Kim ZF; Kuznetsova TY; Lareva NV; Makarova EV; Malchikova SV; Nedogoda SV; Petrova MM; Pochinka IG; Protasov KV; Protsenko DN; Ruzanau DY; Sayganov SA; Sarybaev AS; Selezneva NM; Sugraliev AB; Fomin IV; Khlynova OV; Chizhova OY; Shaposhnik II; Sh'ukarev DA; Abdrahmanova АK; Avetisian SA; Avoyan HG; Azarian KK; Aimakhanova GT; Ayipova DA; Akunov AC; Alieva MK; Aparkina AV; Aruslanova OR; Ashina EY; Badina OY; Barisheva OY; Batchayeva AS; Bitieva AM; Bikhteyev IU; Borodulina NA; Bragin MV; Budu AM; Bykova GM; Vagapova KR; Varlamova DD; Vezikova NN; Verbitskaya EA; Vilkova OE; Vinnikova EA; Vustina VV; Galova EA; Genkel VV; Gorshenina EI; Gostishev RV; Grigorieva EV; Gubareva EY; Dabylova GM; Demchenko AI; Dolgikh OY; Duyshobayev MY; Evdokimov DS; Egorova KE; Ermilova AN; Zheldybayeva AE; Zarechnova NV; Zimina YD; Ivanova SY; Ivanchenko EY; Ilina MV; Kazakovtseva MV; Kazymova EV; Kalinina YS; Kamardina NA; Karachenova AM; Karetnikov IA; Karoli NA; Karsiev MK; Кaskaeva DS; Kasymova KF; Kerimbekova ZB; Kerimova AS; Kim ES; Kiseleva NV; Klimenko DA; Klimova AV; Kovalishena OV; Kolmakova EV; Kolchinskaya TP; Kolyadich MI; Kondriakova OV; Konoval MP; Konstantinov DY; Konstantinova EA; Kordukova VA; Koroleva EV; Kraposhina AY; Kriukova TV; Kuznetsova AS; Kuzmina TY; Kuzmichev KV; Kulchoroevna CK; Kuprina TV; Kouranova IM; Kurenkova LV; Kurchugina NY; Kushubakova NA; Levankova VI; Lyubavina NA; Magdeyeva NA; Mazalov KV; Majseenko VI; Makarova AS; Maripov AM; Marusina AA; Melnikov ES; Moiseenko NB; Muradova FN; Muradyan RG; Musaelian SN; Myshak AO; Nekaeva ES; Nikitina NM; Ogurlieva BB; Odegova AA; Omarova YV; Omurzakova NA; Ospanova SO; Pahomova EV; Petrov LD; Plastinina SS; Pogrebetskaya VA; Polyakov DS; Ponomarenko EV; Popova LL; Prokofeva NA; Pudova IA; Rakov NA; Rahimov AN; Rozanova NA; Serikbolkyzy S; Simonov AA; Skachkova VV; Soloveva DV; Soloveva IA; Subbotin AK; Sukhomlinova IM; Sushilova AG; Tagayeva DR; Titojkina YV; Tikhonova EP; Tokmin DS; Tolmacheva AA; Torgunakova MS; Trenogina KV; Trostianetckaia NA; Trofimov DA; Tulichev AA; Tursunova AT; Ulanova ND; Fatenkov OV; Fedorishina OV; Fil TS; Fomina IY; Fominova IS; Frolova IA; Tsvinger SM; Tsoma VV; Cholponbaeva MB; Chudinovskikh TI; Shevchenko OA; Sheshina TV; Shishkina EA; Shishkov KY; Sherbakov SY; Yausheva EA
Ter Arkh; 2022 Jan; 94(1):32-47. PubMed ID: 36286918
[TBL] [Abstract][Full Text] [Related]
6. Chronic comorbidities and clinical outcomes in patients with and without COVID-19: a large population-based study using national administrative healthcare open data of Mexico.
Martos-Benítez FD; Soler-Morejón CD; García-Del Barco D
Intern Emerg Med; 2021 Sep; 16(6):1507-1517. PubMed ID: 33411264
[TBL] [Abstract][Full Text] [Related]
7. The anatomy of COVID-19 comorbidity networks among hospitalized Korean patients.
Shin EK; Choi HY; Hayes N
Epidemiol Health; 2021; 43():e2021035. PubMed ID: 33971700
[TBL] [Abstract][Full Text] [Related]
8. Frequent coexistence of chronic heart failure and chronic obstructive pulmonary disease in respiratory and cardiac outpatients: Evidence from SUSPIRIUM, a multicentre Italian survey.
Griffo R; Spanevello A; Temporelli PL; Faggiano P; Carone M; Magni G; Ambrosino N; Tavazzi L;
Eur J Prev Cardiol; 2017 Apr; 24(6):567-576. PubMed ID: 28067533
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular comorbidities as predictors for severe COVID-19 infection or death.
Phelps M; Christensen DM; Gerds T; Fosbøl E; Torp-Pedersen C; Schou M; Køber L; Kragholm K; Andersson C; Biering-Sørensen T; Christensen HC; Andersen MP; Gislason G
Eur Heart J Qual Care Clin Outcomes; 2021 Mar; 7(2):172-180. PubMed ID: 33107909
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of comorbidity in Chinese patients with COVID-19: systematic review and meta-analysis of risk factors.
Yin T; Li Y; Ying Y; Luo Z
BMC Infect Dis; 2021 Feb; 21(1):200. PubMed ID: 33618678
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature.
Bajgain KT; Badal S; Bajgain BB; Santana MJ
Am J Infect Control; 2021 Feb; 49(2):238-246. PubMed ID: 32659414
[TBL] [Abstract][Full Text] [Related]
12. Analysis of influence of background therapy for comorbidities in the period before infection on the risk of the lethal COVID outcome. Data from the international ACTIV SARS-CoV-2 registry («Analysis of chronic non-infectious diseases dynamics after COVID-19 infection in adult patients SARS-CoV-2»).
Tarlovskaya EI; Arutyunov AG; Konradi AO; Lopatin YM; Rebrov AP; Tereshchenko SN; Chesnikova AI; Hayrapetyan HG; Babin AP; Bakulin IG; Bakulina NV; Balykova LA; Blagonravova AS; Boldina MV; Vaisberg AR; Galyavich AS; Gomonova VV; Grigorieva NY; Gubareva IV; Demko IV; Evzerikhina AV; Zharkov AV; Kamilova UK; Kim ZF; Kuznetsova TY; Lareva NV; Makarova EV; Malchikova SV; Nedogoda SV; Petrova MM; Pochinka IG; Protasov KV; Protsenko DN; Ruzanau DY; Sayganov SA; Sarybaev AS; Selezneva NM; Sugraliev AB; Fomin IV; Khlynova OV; Chizhova OY; Shaposhnik II; Shсukarev DA; Abdrahmanova AK; Avetisian SA; Avoyan HG; Azarian KK; Aimakhanova GT; Ayipova DA; Akunov AC; Alieva MK; Aparkina AV; Aruslanova OR; Ashina EY; Badina OY; Barisheva OY; Batchayeva AS; Bitieva AM; Bikhteyev IU; Borodulina NA; Bragin MV; Budu AM; Burygina LA; Bykova GA; Vagapova KR; Varlamova DD; Vezikova NN; Verbitskaya EA; Vilkova OE; Vinnikova EA; Vustina VV; Gаlova EA; Genkel VV; Gorshenina EI; Gostishev RV; Grigorieva EV; Gubareva EY; Dabylova GM; Demchenko AI; Dolgikh OY; Duyshobayev MY; Evdokimov DS; Egorova KE; Ermilova AN; Zheldybayeva AE; Zarechnova NV; Zimina YD; Ivanova SY; Ivanchenko EY; Ilina MV; Kazakovtseva MV; Kazymova EV; Kalinina YS; Kamardina NA; Karachenova AM; Karetnikov IA; Karoli NA; Karpov OV; Karsiev MK; Кaskaeva DS; Kasymova KF; Kerimbekova ZB; Kerimova AS; Kim ES; Kiseleva NV; Klimenko DA; Klimova AV; Kovalishena OV; Kolmakova EV; Kolchinskaya TP; Kolyadich MI; Kondriakova OV; Konoval MP; Konstantinov DY; Konstantinova EA; Kordukova VA; Koroleva EV; Kraposhina AY; Kriukova TV; Kuznetsova AS; Kuzmina TY; Kuzmichev KV; Kulchoroeva CK; Kuprina TV; Kouranova IM; Kurenkova LV; Kurchugina NY; Kushubakova NA; Levankova VI; Levin MЕ; Lyubavina NA; Magdeyeva NA; Mazalov KV; Majseenko VI; Makarova AS; Maripov AM; Marusina AA; Melnikov ES; Moiseenko NB; Muradova FN; Muradyan RG; Myshak AO; Nikitina NM; Ogurlieva BB; Odegova AA; Omarova YM; Omurzakova NA; Ospanova SO; Pahomova EV; Petrov LD; Plastinina SS; Pogrebetskaya VA; Polyakov DS; Ponomarenko EV; Popova LL; Prokofeva NA; Pudova IA; Rakov NA; Rakhimov AN; Rozanova NA; Serikbolkyzy S; Simonov AA; Skachkova VV; Soloveva DV; Soloveva IA; Sokhova FM; Subbotin AK; Sukhomlinova IM; Sushilova AG; Tagayeva DR; Titojkina YV; Tikhonova EP; Tokmin DS; Tolmacheva AA; Torgunakova MS; Trenogina KV; Trostianetckaia NA; Trofimov DA; Tulichev AA; Tursunova AT; Ulanova ND; Fatenkov OV; Fedorishina OV; Fil TS; Fomina IY; Fominova IS; Frolova IA; Tsvinger SM; Tsoma VV; Cholponbaeva MB; Chudinovskikh TI; Shevchenko OA; Sheshina TV; Shishkina EA; Shishkov KY; Sherbakov SY; Yausheva EA; Musaelian SN; Belenkov YN; Arutyunov GP
Kardiologiia; 2021 Sep; 61(9):20-32. PubMed ID: 34713782
[TBL] [Abstract][Full Text] [Related]
13. Arterial hypertension and chronic obstructive pulmonary disease: clinical characteristics and treatment efficasy (according to the national register of arterial hypertension).
Chazova IE; Lazareva NV; Oshchepkova EV
Ter Arkh; 2019 Mar; 91(3):4-10. PubMed ID: 31094451
[TBL] [Abstract][Full Text] [Related]
14. Incidence and risk factors of atrial fibrillation in Asian COPD patients.
Liao KM; Chen CY
Int J Chron Obstruct Pulmon Dis; 2017; 12():2523-2530. PubMed ID: 28883719
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of co-morbidities and their association with mortality in patients with COVID-19: A systematic review and meta-analysis.
Singh AK; Gillies CL; Singh R; Singh A; Chudasama Y; Coles B; Seidu S; Zaccardi F; Davies MJ; Khunti K
Diabetes Obes Metab; 2020 Oct; 22(10):1915-1924. PubMed ID: 32573903
[TBL] [Abstract][Full Text] [Related]
16. Coronavirus disease (COVID-19): A systematic review and meta-analysis to evaluate the impact of various comorbidities on serious events.
Nandy K; Salunke A; Pathak SK; Pandey A; Doctor C; Puj K; Sharma M; Jain A; Warikoo V
Diabetes Metab Syndr; 2020; 14(5):1017-1025. PubMed ID: 32634716
[TBL] [Abstract][Full Text] [Related]
17. Clinical determinants of the severity of COVID-19: A systematic review and meta-analysis.
Li X; Zhong X; Wang Y; Zeng X; Luo T; Liu Q
PLoS One; 2021; 16(5):e0250602. PubMed ID: 33939733
[TBL] [Abstract][Full Text] [Related]
18. [Retrospective study on the prevalence of cardiovascular comorbidities in 4960 inpatients with chronic obstructive pulmonary disease in Beijing].
Wei ZM; Cai JF; Cui H; Liu AM; Li Y; Gao F; Fan L
Zhonghua Liu Xing Bing Xue Za Zhi; 2011 Mar; 32(3):297-301. PubMed ID: 21457669
[TBL] [Abstract][Full Text] [Related]
19. Mortality of COVID-19 is associated with comorbidity in patients with chronic obstructive pulmonary disease.
Andreen N; Andersson LM; Sundell N; Gustavsson L; Westin J
Infect Dis (Lond); 2022 Jul; 54(7):508-513. PubMed ID: 35287524
[TBL] [Abstract][Full Text] [Related]
20. Clinical Characteristics and Outcomes of Patients with Severe COVID-19 and Chronic Obstructive Pulmonary Disease (COPD).
He Y; Xie M; Zhao J; Liu X
Med Sci Monit; 2020 Sep; 26():e927212. PubMed ID: 32883943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
